Fig. 8

Verification of prognostic genes. A Differential protein expression of EMILIN2, SURF4, or LYPLA1 in breast cancer patients, as determined by immunohistochemistry. Representative images of low and high expression are shown. B Kaplan-Meier survival curves for breast cancer patients stratified by protein expression levels of EMILIN2, SURF4, or LYPLA1. Patients with higher protein levels have worse overall survival. C The bulk RNA sequencing data and clinical information of breast cancer were downloaded from the TCGA database. Subsequently, kaplan-Meier survival analysis were conducted for breast cancer patients. Patients with higher RNA levels have worse overall survival. The p values were calculated using the log-rank test